- Home
- ABEO vs TSVT Comparison
ABEO vs TSVT Comparison
Compare ABEO & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- TSVT
- Stock Information
- Founded
- ABEO N/A
- TSVT 2021
- Country
- ABEO United States
- TSVT United States
- Employees
- ABEO N/A
- TSVT N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- ABEO Health Care
- TSVT Health Care
- Exchange
- ABEO Nasdaq
- TSVT Nasdaq
- Market Cap
- ABEO 247.8M
- TSVT 160.4M
- IPO Year
- ABEO 1980
- TSVT N/A
- Fundamental
- Price
- ABEO $5.70
- TSVT $3.07
- Analyst Decision
- ABEO Strong Buy
- TSVT Buy
- Analyst Count
- ABEO 3
- TSVT 6
- Target Price
- ABEO $18.00
- TSVT $10.40
- AVG Volume (30 Days)
- ABEO 229.2K
- TSVT 297.4K
- Earning Date
- ABEO 11-14-2024
- TSVT 11-12-2024
- Dividend Yield
- ABEO N/A
- TSVT N/A
- EPS Growth
- ABEO N/A
- TSVT N/A
- EPS
- ABEO N/A
- TSVT N/A
- Revenue
- ABEO N/A
- TSVT $45,620,000.00
- Revenue This Year
- ABEO N/A
- TSVT N/A
- Revenue Next Year
- ABEO $18,714.71
- TSVT $36.09
- P/E Ratio
- ABEO N/A
- TSVT N/A
- Revenue Growth
- ABEO 147.52
- TSVT N/A
- 52 Week Low
- ABEO $3.05
- TSVT $2.78
- 52 Week High
- ABEO $9.01
- TSVT $6.40
- Technical
- Relative Strength Index (RSI)
- ABEO 34.30
- TSVT 32.27
- Support Level
- ABEO $5.45
- TSVT $2.78
- Resistance Level
- ABEO $6.04
- TSVT $4.07
- Average True Range (ATR)
- ABEO 0.19
- TSVT 0.24
- MACD
- ABEO -0.04
- TSVT -0.05
- Stochastic Oscillator
- ABEO 19.47
- TSVT 12.02
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.